Get it on Google Play

LGND Says Pfizer Submits SNDA for Lasofoxifene

February 3, 2005 9:03 AM EST Send to a Friend
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) announced that Pfizer (NYSE: PFE) has confirmed a December 2004 FDA filing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login